Companies: 10,795·Total market cap: $144.5T
Galecto, Inc.

Galecto, Inc.

GLTONASDAQHealthcare
$21.58
$-0.75(-3.36%)
Market Cap$34470166
P/E Ratio—
52W High$38.325
52W Low$2.01
SEC Filings

Galecto, Inc. (GLTO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001800315 · GLTO · NASDAQ · as of Jun 9, 2026

Filing snapshot

329
Total Filings
SCHEDULE 13G/A
Latest Form
2026-05-15
Most Recent
2020
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001800315 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-19
Fiscal Year End
Mar 19, 2026
Accession No.
0001193125-26-115922
Primary Document
dmra-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001800315 · Accession 0001193125-26-115922

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-12
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-04Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-12
View
3Initial Statement of Beneficial Ownership
3
2026-05-08
View
8-KCurrent Report
8-K
2026-05-04
View
ARSARS
ARS
2026-05-01
View
DEF 14AProxy Statement
DEF 14A
2026-04-29
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-29
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-04-23
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-04-23
View
8-KCurrent Report
8-K
2026-04-20
View
3Initial Statement of Beneficial Ownership
3
2026-04-01
View
3Initial Statement of Beneficial Ownership
3
2026-03-25
View
3Initial Statement of Beneficial Ownership
3
2026-03-25
View
Showing 1–15 of 189 filingsForm 4 / 144 hidden· 329 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001800315  |  Exchange: NASDAQ · Healthcare

Galecto, Inc. (NASDAQ: GLTO) has submitted 329 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001800315, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Galecto, Inc.'s most comprehensive regulatory disclosure. The most recent Galecto, Inc. 10-K was filed on 2026-03-19 for fiscal year ending 2026. Historical GLTO 10-K annual reports are available from 2020 through 2026.

Investors researching Galecto, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
PHIO SEC Filings →KPRX SEC Filings →INAB SEC Filings →APVO SEC Filings →BCDA SEC Filings →RNAZ SEC Filings →APRE SEC Filings →ACXP SEC Filings →
→ GLTO Financials→ GLTO Earnings→ GLTO Insider Trades

Frequently Asked Questions

GLTO SEC Filings · 8 questions

Galecto, Inc. (GLTO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 329 filings and access original documents at no cost. Galecto, Inc.'s CIK is 0001800315.

GLTO SEC filingsGalecto, Inc. SEC documentsfind GLTO 10-K